Al Hikma
- Company typePrivate
- Founded2005
- HeadquartersDubai, United Arab Emirates
- Headcount—
- GTM typeB2B
- OfferingServices
Al Hikma firmographics
Firmographics- Name
- Al Hikma
- Legal name
- Al Hikma Group
- Website
- https://alhikmaco.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Ownership category
- akta.pro rank
Al Hikma industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- OTC & Consumer Health Distributors (HLAIAJAC)
Keywords
Where Al Hikma is headquartered
LocationHeadquarters
- HQ city
- Dubai
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Al Hikma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Operations, Others
Revenue model
- Healthcare Product Distribution: Al Hikma distributes and markets international healthcare brands across the MENA region, generating revenue through distribution margins and marketing services for pharmaceutical, wound care, nutraceutical, and medical device products.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Al Hikma product offering
Product offeringCore offering
Al Hikma Group distributes and markets pharmaceutical, wound care, nutraceutical, medical diagnostic, and medical disposable products across the MENA and African regions. The company serves as exclusive regional agent and distributor for 20+ international healthcare brands, handling product registration, marketing, and distribution through a network of 50+ local distributors and resellers across 25+ countries. Its portfolio includes over 500 products, with blockbuster brands such as BloodSTOP iX, Flamigel, Meiact, ArthriFlex, Antos, Lozaty, and Cystone.
Product overview
Al Hikma Group is a pharmaceutical and healthcare products distributor established in Dubai, UAE in 2005. The company distributes and markets world-class healthcare products across five main categories: Pharmaceuticals (including Tabuk Pharmaceuticals, Grandis Pharmaceuticals, Swiss Parenteral, LUCA AI Cell, and others), Wound Care (including Flen Health, LifeScience Plus, Anscare, Eurofarm, JeNaCell, Zuiko), Nutraceuticals (including Adrien Gagnon, Himalaya, Lozaty), Medical Diagnostics (including Spengler, Stanom), and Medical Disposables (including 3M, Canusoft). The portfolio includes over 500 products from 20+ international brands distributed across 25+ countries, covering 500+ million populations with 500+ employees and 20+ years of experience. Key blockbuster branded products include BloodSTOP iX hemostatic agent, Meiact antibiotic, Flamigel wound healing gel, ArthriFlex pain relief cream, Antos cough syrup, Lozaty lozenges, and Cystone kidney stone supplement.
Differentiator
Problem solved
Functional benefit
Products and services
- Tabuk Pharmaceuticals Leading Saudi pharmaceutical manufacturer with more than 100 products, distributed by Al Hikma across the MENA region. Flagship product Meiact (cefditoren pivoxil) is a fourth-generation cephalosporin antibiotic for bronchitis, pneumonia, and infections of skin, throat, and tonsils.
- Lagap Swiss pharmaceutical manufacturer distributed by Al Hikma.
- Grandis Pharmaceuticals Innovative Canadian pharmaceutical and nutraceutical manufacturer with 3 manufacturing sites in Canada, USA, and Spain. Specializes in providing specialized supplements to manage or treat certain medical conditions from natural origin. Flagship product Antos is a cough syrup with natural formula containing echinacea, honey, and thyme, available in adult and children's formulas.
- SceiGen
- Pharmax
- Pharmathen
- Unimed
- Deef Pharmaceuticals
- Swiss Parenteral Leading pharmaceutical manufacturer based in India with more than 80 exporting countries. Manufacturing site and products approved by European GMP, Australian TGA, and WHO-GMP. Distributed by Al Hikma across MENA markets.
- LUCA AI Cell South Korean bio platforms company developing broad spectrum antiviral treatment, drug delivery system, and diagnostic and preventive medical devices using nano-based Lipid technologies. Distributed exclusively by Al Hikma.
- Flen Health Innovative wound care products developer from Belgium, specializing in products like Flaminal and Flamigel. Flamigel is a hydro-active colloid gel that contributes to faster wound healing and prevention of scar formation based on moist wound healing principles.
- LifeScience Plus USA-based wound care manufacturer and developer of BloodSTOP iX, a next-generation hemostatic agent for surgery, emergency trauma care, paramedics, ulcers, and dental wounds. Biocompatible, non-irritating, and made from natural plant-based materials.
- Anscare Taiwan-based wound care manufacturer (backed by BenQ Materials) that develops advanced medical-grade products covering clinical hemostasis solutions, wound management, and scar care. Distributed exclusively by Al Hikma.
- Eurofarm Italian medical device manufacturer specialized in research, production and distribution of first-aid plasters, sterile surgical dressings, incision drapes, bandages and advanced medical devices for wound treatment. Distributed exclusively by Al Hikma.
- JeNaCell German company (part of Evonik) focused on developing and producing high-quality products using biosynthetic cellulose, a nature-inspired material. Distributed exclusively by Al Hikma.
- Zuiko
- Adrien Gagnon Canadian nutraceutical manufacturer producing products such as ArthriFlex, Digest 365, Neoflex Joint repair, and Omega 3 enriched formula. ArthriFlex is a natural, non-greasy analgesic cream providing relief from arthritis, rheumatic pain, muscle stiffness, sciatica, bursitis, lumbago, back pain, and sprains.
- Himalaya
- Lozaty Premium quality lozenges manufactured in USA FDA approved facility in Turkey, available in 7 flavors (Ginger, Cola, Menthol, Lemon & Honey, Orange, Propolis Sugar Free, Strawberry Sugar Free) for relief of nasal and throat congestion. Al-Hikma Group UAE is the MA Holder.
- Spengler Medical Devices
- Stanom
- 3M Medical Disposables
- Canusoft
Companies that use Al Hikma
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Al Hikma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Al Hikma partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core, flagship and minor.
- Tabuk PharmaceuticalscoreTabuk Pharmaceuticals is a leading Saudi pharmaceutical manufacturer with more than 100 products. Al Hikma Group, with its local distributor in Yemen, relaunched Tabuk Pharmaceutical products in Yemen in Q1 2023.
- Swiss ParenteralcoreSwiss is a leading pharmaceutical manufacturer based in India with more than 80 exporting countries. Manufacturing site/products are approved by European GMP, Australian TGA, WHO-GMP and many others. Al Hikma successfully launched Swiss Parenteral Ltd products in Iraq.
- Grandis PharmaceuticalscoreGrandis Pharmaceutical is an innovative Canadian company specialized in manufacturing nutraceutical products with 3 manufacturing sites in Canada, USA, and Spain. Grandis specializes in providing specialized supplements to manage/treat certain medical conditions from natural origin with high quality and competitive pricing. Successfully launched in Iraq and Mauritius.
- Flen HealthflagshipFlen Health is an innovative wound care products developer including Flaminal and Flamigel. Al Hikma Group to relaunch Flen Health in UAE by Q4 2022. Al Hikma represents Flen Health at major wound care conferences.
- LifeScience PluscoreLifeScience Plus is a USA-based company. Al Hikma represents LifeScience Plus products including BloodSTOP iX hemostatic agent. Successfully launched BloodSTOP iX in Bahrain.
- JeNaCellflagshipJeNaCell, an Evonik company based in Germany, focuses on developing and producing high-quality products using biosynthetic cellulose. ALHIKMA is appointed as exclusive agent for JeNaCell Germany.
- Anscare (BenQ Materials)coreAnscare, Taiwan, develops advanced medical-grade products covering clinical hemostasis solutions, wound management, and scar care. Packed by BenQ Materials with in-house technical expertise. ALHIKMA is appointed as exclusive agent for Anscare.
- EurofarmcoreEurofarm Spa is a leading Italian medical device manufacturing company specialized in research, production and distribution of first-aid plasters, sterile surgical dressings, incision drapes, bandages and advanced medical devices for wound treatment. ALHIKMA is appointed as exclusive agent for Eurofarm Italy.
- LUCA AI CellflagshipLUCA AICell is a South Korean bio platforms company developing broad spectrum antiviral treatment, drug delivery system, and diagnostic/preventive medical devices using nano-based Lipid technologies. ALHIKMA is appointed as exclusive agent for LUCA AI Cell South Korea.
- Adrien GagnoncoreAdrien Gagnon is a Canadian nutraceutical company. Al Hikma, with its local distributor, launched Adrien Gagnon products for the first time in Egypt.
- HimalayacoreHimalaya is an Indian wellness company. Products include Cystone for kidney stone management and urinary tract support.
- LozatycoreLozaty is a premium quality lozenges brand manufactured in USA FDA approved facility in Turkey. MA Holder by Al-Hikma Group UAE. Successfully launched in Jordan and Ghana, registered in Egypt.
- 3Mcore3M is a global American company manufacturing medical disposables and healthcare products. Products distributed include medical supplies.
- LagapminorLagap is a Swiss pharmaceutical company represented in the portfolio.
- SceiGenminorSceiGen is a USA-based pharmaceutical company in the portfolio.
- PharmaxminorPharmax is a UAE-based pharmaceutical company in the portfolio.
- PharmathenminorPharmathen is a Greece-based pharmaceutical company in the portfolio.
- UnimedminorUnimed is a Tunisia-based pharmaceutical company in the portfolio.
- Deef PharmaceuticalsminorDeef Pharmaceuticals is a Saudi Arabia-based pharmaceutical company in the portfolio.
- ZuikocoreZuiko is a Japan-based company in the wound care portfolio. Al Hikma exhibited at Pregnancy Summit representing Zuiko.
- CanusoftminorCanusoft is a Canadian company manufacturing medical disposables.
- StanomminorStanom is a USA-based company in the medical diagnostics portfolio.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Al Hikma competitors and assessment
Company assessmentDirect peers
- MS Pharma: Jordan-based pharmaceutical marketing and distribution company operating across MENA with proprietary generics and in-licensed brands. Closest comparable to Al Hikma given its agency-style distribution model, MENA geographic focus, and multi-country footprint.
- Pharma International Co. Jordan-based pharmaceutical manufacturer and regional distributor operating across MENA markets. Comparable MENA distribution and marketing model with multi-country footprint.
Broad incumbents
- Hikma Pharmaceuticals: Leading MENA-headquartered (Jordan) multinational pharmaceutical manufacturer and distributor with branded generics, injectables, and consumer health operations. Comparable as a MENA pharma distributor/marketer, though operates its own manufacturing footprint at far larger scale.
- Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer and distributor with broad MENA presence across branded generics and consumer health. Comparable as a UAE-headquartered regional pharma player, though larger and manufacturing-led.
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi Arabia's leading pharmaceutical manufacturer and distributor operating across the GCC and MENA. Comparable regional pharma distribution footprint, though vertically integrated with manufacturing.
- Tamer Group: Saudi Arabian diversified healthcare conglomerate with distribution of international pharma, medical devices, and consumer health brands across MENA. Comparable as a regional distributor of third-party healthcare brands.
- Jamjoom Pharmaceuticals: Saudi Arabia-based pharmaceutical manufacturer and marketer with branded generics distributed across MENA. Comparable regional pharma distribution business, though primarily a manufacturer.
- Ali Bin Ali Group: Qatari diversified conglomerate with a healthcare and pharmaceuticals distribution division distributing international brands across MENA. Comparable as a regional distributor of third-party pharma and medical brands.
- Tabuk Pharmaceuticals: Saudi Arabia-headquartered pharmaceutical manufacturer with 100+ products distributed across MENA. Listed as an Al Hikma principal partner, but operates its own regional distribution and overlaps in therapeutic categories; a larger player with proprietary products.
Emerging players
- Avalon Pharma: Saudi Arabia-based pharmaceutical company focused on dermatology, dermo-cosmetics, and specialty products distributed across MENA. Comparable regional pharma marketing/distribution model in a specialty niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Al Hikma social profiles
Digital presenceAl Hikma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Al Hikma leadership team
Management profileNumber of profiles
Profiles1 record
Al Hikma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Al Hikma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Al Hikma
What does Al Hikma do?
Al Hikma Group distributes and markets pharmaceutical, wound care, nutraceutical, medical diagnostic, and medical disposable products across the MENA and African regions. The company serves as exclusive regional agent and distributor for 20+ international healthcare brands, handling product registration, marketing, and distribution through a network of 50+ local distributors and resellers across 25+ countries. Its portfolio includes over 500 products, with blockbuster brands such as BloodSTOP iX, Flamigel, Meiact, ArthriFlex, Antos, Lozaty, and Cystone.
Is Al Hikma a public or private company?
Al Hikma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Al Hikma founded?
Al Hikma was founded in 2005.
Where is Al Hikma based?
Al Hikma is headquartered in Dubai, United Arab Emirates, in the Middle East region.
How does Al Hikma make money?
One revenue line is on record: healthcare Product Distribution.
Who are Al Hikma's main competitors?
Direct peers on record are MS Pharma and Pharma International Co.. Broad incumbents are Hikma Pharmaceuticals, Julphar (Gulf Pharmaceutical Industries), SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances), Tamer Group, Jamjoom Pharmaceuticals, Ali Bin Ali Group and Tabuk Pharmaceuticals. Avalon Pharma is listed as an emerging player.
Does Al Hikma have an API?
No public API is recorded for Al Hikma.
What industry is Al Hikma in?
Al Hikma's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors. Its NAICS code is 42421 and its SIC code is 5122.